News

A Drug that Could Reduce Metastatic Cancer Resurgence due to Its Anti-Inflammatory Effects in Viral Infections is in Clinical Trials

SHELTON, CONNECTICUT / ACCESS Newswire / August 18, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the ...
Guelph Mercury-Tribune36m

Health Canada approves this fall’s COVID-19 vaccine. Here’s what you need to know

Health Canada announced it has approved a new vaccine made by Pfizer Canada and BioNTech for the fall of 2025. According to ...